Cardium Therapeutics Inc. (CXM) is “One to Watch”
Cardium Therapeutics Inc. acquires and strategically develops new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to commercialization, partnering and other opportunities for monetization. The company’s investment portfolio currently includes the Tissue Repair Company and Cardium Biologics. Cardium Therapeutics’ business model aims to create multiple opportunities for success, avoiding reliance on any single technology platform or product type, while leveraging its skills in late-stage product development. The company’s long-term strategy is to pursue cost-effective acquisitions with strong value enhancement potential as product opportunities and businesses are advanced and…